BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32737686)

  • 1. Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose.
    Wild CM; Stieg M; Stalla GK; Auer MK; Athanasoulia-Kaspar AP
    Qual Life Res; 2020 Dec; 29(12):3325-3331. PubMed ID: 32737686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone.
    Barlas T; Yalcin MM; Avci DE; Kaplan Y; Akturk M; Toruner FB; Karakoc A; Altinova AE
    Pituitary; 2023 Aug; 26(4):411-418. PubMed ID: 37261656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life but not Cognition is Impacted by Radiotherapy in Patients with Non-Functioning Pituitary Adenoma.
    Crouzeix G; Morello R; Thariat J; Morera J; Joubert M; Reznik Y
    Horm Metab Res; 2019 Mar; 51(3):178-185. PubMed ID: 30861564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas.
    Leistner SM; Klotsche J; Dimopoulou C; Athanasoulia AP; Roemmler-Zehrer J; Pieper L; Schopohl J; Wittchen HU; Stalla GK; Fulda S; Sievers C
    Eur J Endocrinol; 2015 Jun; 172(6):733-43. PubMed ID: 25792374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas.
    Vega-Beyhart A; Enriquez-Estrada VM; Bello-Chavolla OY; Torres-Victoria TR; Martínez-Sánchez FD; López-Navarro JM; Pérez-Guzmán MC; Hinojosa-Amaya JM; León-Suárez A; Espinoza-Salazar HD; Roldán-Sarmiento P; Gómez-Sámano MA; Gómez-Pérez FJ; Cuevas-Ramos D
    Clin Endocrinol (Oxf); 2019 Mar; 90(3):457-467. PubMed ID: 30548674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.
    Zueger T; Kirchner P; Herren C; Fischli S; Zwahlen M; Christ E; Stettler C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1938-42. PubMed ID: 22872686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients treated for nonfunctioning pituitary adenomas during the years 2000-2010.
    Karppinen A; Ritvonen E; Roine R; Sintonen H; Vehkavaara S; Kivipelto L; Grossman AB; Niemelä M; Schalin-Jäntti C
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):532-9. PubMed ID: 26493182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.
    Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Sluiter WJ; Tucha O; Wolffenbuttel BH; van Beek AP
    Neuroendocrinology; 2016; 103(6):771-8. PubMed ID: 26646751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NONFUNCTIONING PITUITARY ADENOMAS UNDERGOING POSTOPERATIVE RADIATION THERAPY: A CASE-CONTROL STUDY.
    González B; Vargas G; Espinosa E; Mendoza-Zubieta V; Ferreira-Hermosillo A; Zárate A; Rodríguez A; Mercado M
    Endocr Pract; 2016 May; 22(5):540-5. PubMed ID: 26684151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Nonfunctioning Pituitary Adenomas That Cause Secondary Adrenal Insufficiency.
    Oshino S; Saitoh Y; Kinoshita M; Mukai K; Otsuki M; Kishima H
    World Neurosurg; 2021 Sep; 153():e275-e281. PubMed ID: 34186215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency.
    Gasco V; Giannelli J; Campioni L; Arvat E; Ghigo E; Grottoli S; Maccario M; Giordano R
    J Endocrinol Invest; 2023 Mar; 46(3):587-597. PubMed ID: 36251244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep patterns in patients treated for non-secreting intra- and parasellar tumors: A self-report case-control study.
    Wild CM; Stieg M; Stalla GK; Jung-Sievers C; Auer MK; Athanasoulia-Kaspar AP
    Front Endocrinol (Lausanne); 2022; 13():1044197. PubMed ID: 36506041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with a pituitary adenoma.
    Johnson MD; Woodburn CJ; Vance ML
    Pituitary; 2003 Sep; 6(2):81-7. PubMed ID: 14703017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and health-related quality of life following traumatic brain injury.
    Gorgoraptis N; Zaw-Linn J; Feeney C; Tenorio-Jimenez C; Niemi M; Malik A; Ham T; Goldstone AP; Sharp DJ
    NeuroRehabilitation; 2019; 44(3):321-331. PubMed ID: 31177238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
    Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
    Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.
    van der Klaauw AA; Kars M; Biermasz NR; Roelfsema F; Dekkers OM; Corssmit EP; van Aken MO; Havekes B; Pereira AM; Pijl H; Smit JW; Romijn JA
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):775-84. PubMed ID: 18462264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.
    Quinkler M; Miodini Nilsen R; Zopf K; Ventz M; Øksnes M
    Eur J Endocrinol; 2015 May; 172(5):619-26. PubMed ID: 25656494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma.
    Hammarstrand C; Ragnarsson O; Hallén T; Andersson E; Skoglund T; Nilsson AG; Johannsson G; Olsson DS
    Eur J Endocrinol; 2017 Sep; 177(3):251-256. PubMed ID: 28596421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with adrenal insufficiency hate their medication: concerns and stronger beliefs about the necessity of hydrocortisone intake are associated with more negative illness perceptions.
    Tiemensma J; Andela CD; Pereira AM; Romijn JA; Biermasz NR; Kaptein AA
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3668-76. PubMed ID: 25226291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.